Abivax Total Assets from 2010 to 2026

ABVX Stock

117.10 0.30 0.26%

Abivax SA Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-12-31

Previous Quarter

119.6 M

Current Value

652.1 M

Quarterly Volatility

134 M

Yuan Drop

Covid

Check Abivax SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abivax SA's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 3 M or Selling General Administrative of 39.8 M, as well as many indicators such as Price To Sales Ratio of 33.77, Dividend Yield of 0.0 or PTB Ratio of 7.67. Abivax financial statements analysis is a perfect complement when working with Abivax SA Valuation or Volatility modules.

Build AI portfolio with Abivax Stock

Check out the analysis of Abivax SA Correlation against competitors.

Latest Abivax SA's Total Assets Growth Pattern

Below is the plot of the Total Assets of Abivax SA American over the last few years. Total assets refers to the total amount of Abivax SA assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Abivax SA American books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Abivax SA's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abivax SA's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 205.23 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Abivax Total Assets Regression Statistics

	Arithmetic Mean	103,556,528
	Geometric Mean	77,575,452
	Coefficient Of Variation	87.70
	Mean Deviation	71,477,926
	Median	60,597,000
	Standard Deviation	90,814,424
	Sample Variance	8247.3T
	Range	289.1M
	R-Value	0.79
	Mean Square Error	3357.5T
	R-Squared	0.62
	Significance	0.0002
	Slope	14,141,522
	Total Sum of Squares	131956.2T

Abivax Total Assets History

	2026	247.8 M
	2025	236 M
	2024	205.2 M
	2023	327.1 M
	2022	75.5 M
	2021	109.2 M
	2020	71.3 M

Other Fundumenentals of Abivax SA American

Intangibles To Total Assets

Abivax SA Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Retained Earnings	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Long Term Investments
Total Assets		0.67	-0.85	0.95	0.95	-0.82	-0.02	0.9	1.0	-0.88	0.82	0.84	0.95	0.14	-0.52	0.8	0.96	0.43	0.94	0.93	0.86	-0.53
Total Stockholder Equity	0.67		-0.95	0.42	0.47	-0.36	0.47	0.28	0.68	-0.31	0.21	0.34	0.43	0.18	-0.33	0.22	0.75	-0.02	0.44	0.81	0.33	-0.04
Net Debt	-0.85	-0.95		-0.65	-0.68	0.58	-0.23	-0.53	-0.85	0.55	-0.45	-0.56	-0.65	-0.17	0.43	-0.48	-0.92	-0.09	-0.65	-0.95	-0.56	0.25
Accounts Payable	0.95	0.42	-0.65		0.98	-0.85	-0.22	0.99	0.95	-0.96	0.92	0.89	0.98	0.06	-0.52	0.87	0.87	0.54	0.97	0.81	0.9	-0.6
Net Receivables	0.95	0.47	-0.68	0.98		-0.84	-0.14	0.96	0.95	-0.94	0.92	0.88	0.96	-0.03	-0.53	0.84	0.87	0.48	0.94	0.82	0.89	-0.59
Good Will	-0.82	-0.36	0.58	-0.85	-0.84		0.16	-0.84	-0.81	0.89	-0.89	-0.97	-0.87	-0.14	0.74	-0.78	-0.78	-0.46	-0.86	-0.72	-0.96	0.64
Short Term Investments	-0.02	0.47	-0.23	-0.22	-0.14	0.16		-0.3	-0.02	0.2	-0.3	-0.2	-0.17	0.15	0.02	-0.31	-0.03	-0.13	-0.18	0.02	-0.22	0.31
Total Liab	0.9	0.28	-0.53	0.99	0.96	-0.84	-0.3		0.89	-0.96	0.94	0.89	0.97	0.07	-0.47	0.9	0.79	0.58	0.96	0.72	0.91	-0.67
Total Current Assets	1.0	0.68	-0.85	0.95	0.95	-0.81	-0.02	0.89		-0.88	0.82	0.83	0.94	0.14	-0.51	0.8	0.96	0.43	0.94	0.93	0.85	-0.52
Retained Earnings	-0.88	-0.31	0.55	-0.96	-0.94	0.89	0.2	-0.96	-0.88		-0.96	-0.91	-0.97	-0.02	0.6	-0.84	-0.79	-0.67	-0.96	-0.71	-0.92	0.56
Short Term Debt	0.82	0.21	-0.45	0.92	0.92	-0.89	-0.3	0.94	0.82	-0.96		0.93	0.93	-0.11	-0.59	0.8	0.71	0.64	0.92	0.64	0.94	-0.65
Intangible Assets	0.84	0.34	-0.56	0.89	0.88	-0.97	-0.2	0.89	0.83	-0.91	0.93		0.92	0.15	-0.76	0.75	0.75	0.57	0.92	0.69	0.99	-0.63
Common Stock	0.95	0.43	-0.65	0.98	0.96	-0.87	-0.17	0.97	0.94	-0.97	0.93	0.92		0.11	-0.59	0.83	0.85	0.65	1.0	0.78	0.93	-0.54
Current Deferred Revenue	0.14	0.18	-0.17	0.06	-0.03	-0.14	0.15	0.07	0.14	-0.02	-0.11	0.15	0.11		-0.06	0.18	0.14	0.02	0.15	0.14	0.16	-0.17
Net Tangible Assets	-0.52	-0.33	0.43	-0.52	-0.53	0.74	0.02	-0.47	-0.51	0.6	-0.59	-0.76	-0.59	-0.06		-0.2	-0.45	-0.49	-0.6	-0.42	-0.69	0.08
Long Term Debt	0.8	0.22	-0.48	0.87	0.84	-0.78	-0.31	0.9	0.8	-0.84	0.8	0.75	0.83	0.18	-0.2		0.77	0.33	0.81	0.7	0.8	-0.8
Net Invested Capital	0.96	0.75	-0.92	0.87	0.87	-0.78	-0.03	0.79	0.96	-0.79	0.71	0.75	0.85	0.14	-0.45	0.77		0.25	0.84	0.99	0.77	-0.49
Short Long Term Debt	0.43	-0.02	-0.09	0.54	0.48	-0.46	-0.13	0.58	0.43	-0.67	0.64	0.57	0.65	0.02	-0.49	0.33	0.25		0.68	0.15	0.55	-0.02
Capital Stock	0.94	0.44	-0.65	0.97	0.94	-0.86	-0.18	0.96	0.94	-0.96	0.92	0.92	1.0	0.15	-0.6	0.81	0.84	0.68		0.78	0.92	-0.52
Net Working Capital	0.93	0.81	-0.95	0.81	0.82	-0.72	0.02	0.72	0.93	-0.71	0.64	0.69	0.78	0.14	-0.42	0.7	0.99	0.15	0.78		0.71	-0.47
Property Plant Equipment	0.86	0.33	-0.56	0.9	0.89	-0.96	-0.22	0.91	0.85	-0.92	0.94	0.99	0.93	0.16	-0.69	0.8	0.77	0.55	0.92	0.71		-0.7
Long Term Investments	-0.53	-0.04	0.25	-0.6	-0.59	0.64	0.31	-0.67	-0.52	0.56	-0.65	-0.63	-0.54	-0.17	0.08	-0.8	-0.49	-0.02	-0.52	-0.47	-0.7

Click cells to compare fundamentals

About Abivax SA Financial Statements

Abivax SA investors use historical fundamental indicators, such as Abivax SA's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Abivax SA. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	236 M	247.8 M
Intangibles To Total Assets	0.14	0.13

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
V	Visa Class A
MSFT	Microsoft

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC